Hepatitis B in Italy: Where we are ten years after the introduction of mass vaccination

被引:39
作者
Mele, A
Stroffolini, T
Zanetti, AR
机构
[1] Univ Milan, Inst Virol, I-20133 Milan, Italy
[2] Ist Super Sanita, Epidemiol & Biostat Lab, I-00161 Rome, Italy
关键词
hepatitis B; vaccination; immunity;
D O I
10.1002/jmv.10092
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In Italy, a program of vaccination against hepatitis B targeted at the immunisation of persons at high risk began in 1983. In 1991, vaccination became mandatory for all newborns and adolescents. Since then, the vaccine has been given to more than 10 million children, with an outstanding record of safety and efficacy. The coverage rate is globally around 94%, with differences between the Northern and Southern regions, with the latter having the lower acceptance rate. According to the National Surveillance System (SEIEVA),the incidence of acute hepatitis B per 105 inhabitants declined from 5.4 in 1990 to 2 in 2000. The reduction was even greater among 15-24-year-old individuals, where the incidence rate per 105 decreased from 17.3 to 2 in the same period. In parallel with the decline of hepatitis B, hepatitis delta has also declined significantly. Catch-up immunisation of unvaccinated adolescents, as well as an effort to improve the vaccination coverage rate in high-risk groups, are required to ameliorate the efficacy of the vaccination campaign. Routine administration of booster doses of vaccine is not considered necessary to sustain immunity in immunocompetent persons. J. Med. Virol. 67.440-443,2002. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:440 / 443
页数:4
相关论文
共 20 条
[1]   Ad hoc survey of hepatitis B vaccination campaign in newborns of HBsAg positive mothers and in 12-year-old subjects in southern Italy [J].
Adamo, B ;
Stroffolini, T ;
Sagliocca, L ;
Simonetti, A ;
Iadanza, F ;
Fossi, E ;
Tancredi, F ;
Mele, A .
VACCINE, 1998, 16 (08) :775-777
[2]   Hepatitis B vaccination and the risk of multiple sclerosis [J].
Ascherio, A ;
Zhang, SM ;
Hernán, MA ;
Olek, MJ ;
Coplan, PM ;
Brodovicz, K ;
Walker, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (05) :327-332
[3]  
Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6
[4]  
BONANNI P, 1995, VACCINE S, V1, P68
[5]   Vaccinations and the risk of relapse in multiple sclerosis [J].
Confavreux, C ;
Suissa, S ;
Saddier, P ;
Bourdés, V ;
Vukusic, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (05) :319-326
[6]   Chronic hepatitis D: A vanishing disease? An Italian multicenter study [J].
Gaeta, GB ;
Stroffolini, T ;
Chiaramonte, M ;
Ascione, T ;
Stornaiuolo, G ;
Lobello, S ;
Sagnelli, E ;
Brunetto, MR ;
Rizzetto, M .
HEPATOLOGY, 2000, 32 (04) :824-827
[7]   LONG-TERM IMMUNOGENICITY AND EFFICACY OF HEPATITIS-B VACCINE IN HOMOSEXUAL MEN [J].
HADLER, SC ;
FRANCIS, DP ;
MAYNARD, JE ;
THOMPSON, SE ;
JUDSON, FN ;
ECHENBERG, DF ;
OSTROW, DG ;
OMALLEY, PM ;
PENLEY, KA ;
ALTMAN, NL ;
BRAFF, E ;
SHIPMAN, GF ;
COLEMAN, PJ ;
MANDEL, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (04) :209-214
[8]   Drug therapy - Vaccines to prevent viral hepatitis [J].
Lemon, SM ;
Thomas, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (03) :196-204
[9]   Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen -: Positive mothers in Italy [J].
Mele, A ;
Tancredi, F ;
Romanò, L ;
Giuseppone, A ;
Colucci, M ;
Sangiuolo, A ;
Lecce, R ;
Adamo, B ;
Tosti, ME ;
Taliani, G ;
Zanetti, AR .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (07) :905-908
[10]  
SAFARY A, 2000, VACCINE, V18, P56